Famotidine: A supplemental drug for the treatment of schizophrenia

P. N. Dannon, E. Lepkifker, I. Iancu, R. Ziv, N. Horesh, M. Kotler

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


In an open-label study, famotidine was added to the regular neuroleptic regimen of 11 schizophrenic patients for 4 weeks. Each patient was scored weekly with SAPS, SANS. CGI and HAM-D-17 scales. The results suggest that famotidine is indeed effective as an adjunctive drug to neuroleptics in the treatment of schizophrenia.

Original languageEnglish
Pages (from-to)263-264
Number of pages2
JournalEuropean Psychiatry
Issue number5
StatePublished - 1997
Externally publishedYes


  • Famotidine
  • H-receptor antagonists
  • Neuroleptics
  • Schizophrenia


Dive into the research topics of 'Famotidine: A supplemental drug for the treatment of schizophrenia'. Together they form a unique fingerprint.

Cite this